Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Reischies, FM; Raggam, RB; Prattes, J; Krause, R; Eigl, S; List, A; Quehenberger, F; Strenger, V; Wölfler, A; Hoenigl, M.
Urine Galactomannan-to-Creatinine Ratio for Detection of Invasive Aspergillosis in Patients with Hematological Malignancies.
J Clin Microbiol. 2016; 54(3):771-774 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Eigl Susanne
Hönigl Martin
Krause Robert
Prattes Jürgen
Quehenberger Franz
Raggam Reinhard Bernd
Reischies Frederike Marie Josefine
Strenger Volker
Wölfler Albert
Altmetrics:

Dimensions Citations:

Plum Analytics:
Number of Figures: 2
| |
Abstract:
Galactomannan (GM) testing of urine specimens may provide important advantages, compared to serum testing, such as easy noninvasive sample collection. We evaluated a total of 632 serial urine samples from 71 patients with underlying hematological malignancies and found that the urine GM/creatinine ratio, i.e., (urine GM level × 100)/urine creatinine level, which takes urine dilution into account, reliably detected invasive aspergillosis and may be a promising diagnostic tool for patients with hematological malignancies. (This study has been registered at ClinicalTrials.gov under registration no. NCT01576653.). Copyright © 2016, American Society for Microbiology. All Rights Reserved.
Find related publications in this database (using NLM MeSH Indexing)
Aspergillosis - diagnosis
Aspergillosis - etiology
Aspergillosis - urine
Biomarkers -
Creatinine - blood
Creatinine - urine
Female -
Hematologic Neoplasms - complications
Humans -
Male -
Mannans - blood
Mannans - urine
Middle Aged -
ROC Curve -
Reproducibility of Results -

© Meduni Graz Impressum